Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ultraviolet Therapy × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3 Lymphoid 3 Genitourinary 2 Dermatologic 2 Breast 2 Thoracic 1 Plasma cell 1 Myeloid 1 Classical hematology 1

Conditions

Pleural Malignancy 1

Interventions

Carboplatin 960 Cisplatin 759 Pemetrexed 705 pembrolizumab 522 Paclitaxel 497 Docetaxel 457 Gemcitabine 354 Radiotherapy 339 Erlotinib Hydrochloride 324 Bevacizumab 282 Nivolumab 279 Etoposide 244 durvalumab 224 Drug Therapy 208 osimertinib 197 atezolizumab 188 Radiosurgery 162 Gefitinib 153 Vinorelbine 131 Magnetic Resonance Spectroscopy 116 Ipilimumab 104 130-nm albumin-bound paclitaxel 104 Cetuximab 95 Topotecan 90 Surgical Procedures, Operative 88 Cyclophosphamide 87 Specimen Handling 85 tislelizumab 82 Irinotecan 81 anlotinib 78

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01673074 2020-04-08

HPPH and PDT for Pleural Malignancy

Abramson Cancer Center at Penn Medicine

Phase 1 Completed

Pleural Malignancy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡